共 50 条
- [4] Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2549 - 2557
- [5] Dietary Patterns and Cardiovascular Disease Risk in People with Type 2 Diabetes [J]. Current Obesity Reports, 2017, 6 : 405 - 413
- [6] Dietary Patterns and Cardiovascular Disease Risk in People with Type 2 Diabetes [J]. CURRENT OBESITY REPORTS, 2017, 6 (04): : 405 - 413
- [8] Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted? [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 387 - 391
- [9] The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease [J]. Current Atherosclerosis Reports, 2016, 18